KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Long-Term Deferred Tax: 2010-2025

Historic Long-Term Deferred Tax for Charles River Laboratories International (CRL) over the last 14 years, with Sep 2025 value amounting to $36.9 million.

  • Charles River Laboratories International's Long-Term Deferred Tax fell 2.78% to $36.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.9 million, marking a year-over-year decrease of 2.78%. This contributed to the annual value of $42.2 million for FY2024, which is 4.72% up from last year.
  • As of Q3 2025, Charles River Laboratories International's Long-Term Deferred Tax stood at $36.9 million, which was down 21.38% from $46.9 million recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Long-Term Deferred Tax peaked at $48.8 million during Q1 2025, and registered a low of $31.9 million during Q2 2021.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $38.5 million (2023), whereas its average is $40.0 million.
  • In the last 5 years, Charles River Laboratories International's Long-Term Deferred Tax fell by 25.48% in 2021 and then spiked by 33.28% in 2022.
  • Charles River Laboratories International's Long-Term Deferred Tax (Quarterly) stood at $40.2 million in 2021, then climbed by 2.58% to $41.3 million in 2022, then decreased by 2.38% to $40.3 million in 2023, then climbed by 4.72% to $42.2 million in 2024, then declined by 2.78% to $36.9 million in 2025.
  • Its Long-Term Deferred Tax stands at $36.9 million for Q3 2025, versus $46.9 million for Q2 2025 and $48.8 million for Q1 2025.